BEP Targeting Strategies in Ethiopia
Targeting Strategies of Antenatal Balanced Energy and Protein Supplementation in Addis Ababa, Ethiopia
Harvard School of Public Health (HSPH)
6,750 participants
Aug 7, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this randomized effectiveness study is to evaluate the different targeting strategies for the delivery of balanced energy and protein (BEP) supplements among pregnant women in Addis Ababa, Ethiopia. The main goals of the study are to: 1) determine the effectiveness of two individual-based antenatal BEP targeting strategies for preventing adverse pregnancy outcomes; 2) compare the cost-effectiveness of the universal BEP provision with two individual-based targeting strategies for preventing adverse pregnancy outcomes; and 3) generate implementation evidence regarding the feasibility and acceptability of different antenatal BEP targeting strategies. Pregnant women will be enrolled during pregnancy, assigned to different strategies of BEP supplementation, and followed from pregnancy through six weeks postpartum to evaluate the impacts of different BEP targeting strategies on pregnancy, maternal, and child outcomes.
Eligibility
Inclusion Criteria8
- pregnant women aged 18 to 49;
- attending antenatal visits in one of the study health facilities;
- with a gestational age of 24 weeks or less;
- no known allergies to peanuts or soybeans;
- having resided in the current location for at least 6 months;
- intending to continue antenatal follow-up in the health facility;
- intending to give birth and remain in the study area until six weeks after delivery; and
- willing to take the BEP supplements for the entire duration of the pregnancy if eligible.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In Arm 2 (targeted BEP based on baseline nutritional status), in addition to the standard of care, participants will receive BEP supplements if their baseline BMI is less than 18.5 or their baseline mid-upper arm circumference is less than 23 cm.
In Arm 3 (targeted BEP based on baseline nutritional status and monthly GWG monitoring), in addition to the standard of care, participants will receive BEP supplements if their baseline BMI is less than 18.5 or their baseline mid-upper arm circumference is less than 23 cm; participants with an inadequate GWG at a monthly follow-up visit will receive additional BEP supplements.
In Arm 4 (universal BEP), all participants will receive BEP supplements from baseline through the end of pregnancy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06125860